Dilemmas in Regulation of the Market for Pharmaceuticals

Health Affairs - United States
doi 10.1377/hlthaff.22.3.31
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Health Affairs (Project Hope)

Related search

Pricing, Patent Loss and the Market for Pharmaceuticals

1991English

Botanical Pharmaceuticals: From Bench to Market

Bocconea
2019English

Pharmaceuticals in the Environment: Scientific Evidence of Risks and Its Regulation

Philosophical Transactions of the Royal Society B: Biological Sciences
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2014English

Early Market Access for Pharmaceuticals in EU: What Is the Impact of Ema’s Accelerated Assessment Procedure?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

The Historical Market for Technology Licenses: Chemicals, Pharmaceuticals, and Electrical Engineering in Imperial Germany

SSRN Electronic Journal
2009English

Government Regulation of the Market for Higher Education

Zhournal Novoi Ekonomicheskoi Associacii
EconomicsEconometricsFinance
2020English

Risk, Resilience and Inequality: Current Dilemmas in Environmental Regulation

English

Regulation, Competition and Risk in the Market for Credit Cards

Canadian Public Policy/ Analyse de Politiques
SociologyPolitical SciencePublic Administration
2000English

The Efficacy of Market Abuse Regulation in the UK

Journal of Financial Regulation and Compliance
ManagementFinanceStrategy
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy